Author Correction: NIPBL-mediated RAD21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer

Commun Biol. 2024 Apr 1;7(1):397. doi: 10.1038/s42003-024-06085-w.

Xiaoling Xu¹, Ding Wang², Weizhen Xu², Huihui Li^{2

3}, Ning Chen⁴, Na Li³, Qifeng Yao³, Wei Chen⁵, Jianxiang Zhong⁶, Weimin Mao^{7

8

9}

¹ Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zhengmin Road, Shanghai, China.
² Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute, 38 Guangji Road, Hangzhou, China.
³ The Second Clinical Medical College of Wenzhou Medical University, 268 West Xueyue Road, Wenzhou, China.
⁴ The Second Clinical Medical College of Zhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, China.
⁵ Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute, 38 Guangji Road, Hangzhou, China. chenwei@zjcc.org.cn.
⁶ School of Life Science and Technology, Southeast University, 2 Sipailou, Nanjing, China. jzhong85109@hotmail.com.
⁷ Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute, 38 Guangji Road, Hangzhou, China. maowm1318@163.com.
⁸ The Second Clinical Medical College of Wenzhou Medical University, 268 West Xueyue Road, Wenzhou, China. maowm1318@163.com.
⁹ Department of Thoracic Oncology, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, 1 Banshan East Road, Hangzhou, China. maowm1318@163.com.

No abstract available

Publication types